# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-03T13:18:13.351269
**Route:** OpenRouter + LaTeX
**Paper Hash:** 26617aea06c1396d
**Tokens:** 17698 in / 1633 out
**Response SHA256:** 7c6fab1a95174169

---

## 1) Data–Design Alignment (Critical)

- **Treatment timing vs. data coverage:** Your design is **not about a policy year**, but about a *daily* cutoff. The **data period (2012–2020)** is consistently stated across Abstract / Data section / Appendix. No place in the paper claims to estimate effects in years outside the data coverage.  
  - The **citation measurement date (early 2025)** is compatible with having outcomes observed long after 2020.
- **Post-“treatment” observations (RDD):** The running variable is minutes from 14:00 ET and the treatment is \( \mathbb{I}[T_i>0] \). You clearly have observations on **both sides** (you show density plots and estimate discontinuities), so no design infeasibility.
- **Treatment definition consistency:** Treatment is consistently defined as “submitted after cutoff,” and used consistently in Table 3 / robustness / narrative.

**No fatal data–design misalignment found.**

---

## 2) Regression Sanity (Critical)

I checked every table that reports estimates:

### Table 2 (Covariate balance)
- SEs and coefficients are all in plausible ranges (e.g., abstract length jump \(-47.96\) with SE \(70.90\)).  
- No impossible values (no NA/Inf; no R² reported; no negative SEs).

### Table 3 (Main RDD results)
- Coefficients for log outcomes are around \(-0.6\) to \(-1.1\) with SEs around \(0.5\)–\(0.9\): **plausible**.
- No “SE wildly larger than coefficient” flags under your fatal-error rules.

### Table 4 (Robustness)
- Estimates and SEs are plausible, including large SEs at small effective N (e.g., 50% optimal bandwidth: SE \(2.48\) with Eff. N = 43). This is not a “broken regression output” per the stated fatal criteria (not enormous like 1000+, not 100× coefficient).

### Table 5 (Heterogeneity)
- Plausible magnitudes; small subsample for stat.ML reflected in larger SE.

**No fatal regression sanity violations found.**

*One thing to sanity-check (not a fatal error under your rules, but worth verifying before submission):*  
- The **industry adoption** estimate is reported in text as \(-0.0007\) with SE \(0.0007\) for a binary outcome. That scale is unusually tiny *if* the variable is truly coded 0/1 and the estimand is a probability-point jump. This could be correct if the variable is inadvertently scaled (e.g., fraction/1000) or if you are reporting something like a mean of a very rare indicator with additional scaling. Make sure the outcome is actually 0/1 in the estimation dataset and that you aren’t, e.g., dividing by 100 somewhere. (Again: not “fatal” by the criteria you gave, but this is the kind of number referees will question.)

---

## 3) Completeness (Critical)

- No placeholders like **TBD / TODO / NA / XXX** in tables.
- Regression tables include **standard errors**.
- Regression tables include **sample size information** in the form of **“Eff. observations / Eff. N”** (this satisfies the requirement that N be reported, given RDD context).
- All cited tables/figures appear to exist as LaTeX objects with labels; none are referenced without being defined in the source.

**No fatal completeness problems found.**

---

## 4) Internal Consistency (Critical)

- Sample sizes are consistent:
  - Weekday sample: **7,412**
  - Matched OpenAlex sample: **1,845**
  - Within ±120 min: **1,820** total, **289** matched
  These figures repeat consistently across Data / Summary table / Appendix.
- Timing is consistent everywhere: **14:00 ET cutoff**, 2012–2020 sample.
- Treatment description matches the empirical implementation (running variable centered at cutoff, \(D_i=\mathbb{I}[T_i>0]\)).

**No fatal internal inconsistencies found.**

---

ADVISOR VERDICT: PASS